Skip to main content
. 2022 Jun 14;44(6):1223–1231. doi: 10.1007/s11096-022-01413-8

Table 3.

Clinical outcomes among patients with diabetes and hypertension

Parameters Diabetes Hypertension

Initial

mean ± SD

Second

mean ± SD

p n

Initial

mean ± SD

Second

mean ± SD

p n
Blood glucose measured at pharmacy (mg/dL) 208.6 ± 90.16 185.2 ± 80.60 0.008 145 167.4 ± 76.88 189.1 ± 77.73 0.064 22
Fasting blood glucose (mg/dL) 173.2 ± 63.70 140.3 ± 44.10 < 0.001 112 150.5 ± 51.60 155.4 ± 62.15 0.632 23
HbA1c (%) 8.8 ± 2.12 7.5 ± 1.82 0.001 57 6.9 ± 2.59 7.1 ± 2.55 0.098 4
LDL-cholesterol (mg/dL) 131.1 ± 46.13 122.5 ± 43.70 0.039 59 146.2 ± 49.37 121.1 ± 29.63 0.061 9
Systolic BP (mmHg) 135.0 ± 19.12 133.5 ± 17.92 0.241 182 139.7 ± 24.14 136.3 ± 21.42 0.008 239
Diastolic BP (mmHg) 79.6 ± 10.73 79.3 ± 11.04 0.739 181 81.5 ± 13.12 80.5 ± 12.43 0.273 240
Medication adherence score (max: 4; goal: 0) 2.1 ± 1.39 2.1 ± 1.12 0.925 57 0.5 ± 0.97 0.3 ± 0.72 < 0.001 171
Insulin injection (min: 0 - max: 10; goal: 10) or BP measurement technique (min: 0 - max: 5; goal: 5) score 7.4 ± 2.43 8.7 ± 2.38 < 0.001 76 3.3 ± 2.16 4.4 ± 1.53 < 0.001 162
Medication knowledge score (min: 0 - max: 8; goal: 8) 4.8 ± 1.27 5.2 ± 1.38 0.021 83 4.8 ± 1.41 5.0 ± 1.29 0.030 170

BP: blood pressure; HbA1c: glycosylated hemoglobin; LDL: low-density lipoprotein; SD: standard deviation